← Back to headlines
NewLimit Claims Aging Reversal Breakthrough, Raises $435 Million for Human Trials
NewLimit, a company backed by Coinbase CEO, claims a breakthrough in aging reversal and has successfully raised $435 million to fund human trials for its research.
4 Jun, 18:31 — 4 Jun, 18:31
Sources
Showing 1 of 1 sources
